CDKL5 and craniodiaphyseal dysplasia: The use of CDD patient-derived iPSC provide a valuable approach to understanding the molecular and cellular functions of CDKL5 in model systems akin to the human brain [54,69,78–81] and can be used to study neural network impairments provide an alternative model system to current animal models.